| 股票代码 | 股票名称 | 持有份额(万股) | 仓位比例 | 涨跌 | 贡献增长率 |
| 600276 | 恒瑞医药 | 55.6200 | 4.87% | -0.67% | -0.0326% |
| 300122 | 智飞生物 | 35.9400 | 4.25% | 0.94% | 0.0400% |
| 600129 | 太极集团 | 45.2000 | 4.06% | -3.63% | -0.1474% |
| 300558 | 贝达药业 | 35.4500 | 3.54% | -3.75% | -0.1328% |
| 300573 | 兴齐眼药 | 9.9900 | 3.52% | -1.43% | -0.0503% |
| 688382 | 益方生物 | 116.8600 | 3.42% | -8.63% | -0.2951% |
| 300765 | 新诺威 | 46.0600 | 3.26% | -3.17% | -0.1033% |
| 688062 | 迈威生物 | 49.9200 | 3.16% | -4.03% | -0.1273% |
| 688076 | 诺泰生物 | 35.2300 | 3.06% | -1.43% | -0.0438% |
| 300760 | 迈瑞医疗 | 5.3900 | 3.03% | -3.50% | -0.1061% |
| 重仓股仓位合计 | 重仓股贡献增长率 | 总持股仓位 | 修正增长率 | ||
| 36.17% | -0.9987% | 91.66% | |||
| 日期 | 实际增长率 | 预估增长率 |
| 2024-04-15 | -0.48% | 0.59% |
| 2024-04-12 | 0.01% | -0.42% |
| 2024-04-11 | -0.36% | -1.09% |
| 2024-04-10 | -1.17% | -1.57% |
| 2024-04-09 | 0.70% | 1.16% |
| 2024-04-08 | -0.84% | -1.09% |
| 2024-04-03 | 0.54% | -0.60% |
| 2024-04-02 | -0.64% | -0.57% |
| 基金名称 | 单位净值 | 日增长率 |
| 浦银安盛颐璇平衡养老目标三年混合(FOF) | 0.9181 | 0.0863% |
| 浦银6个月A | 1.0765 | 0.0013% |
| 浦银6个月C | 1.0729 | 0.0013% |
| 浦银安盛嘉和稳健一年持有混合(FOF)A | 1.0015 | -0.0472% |
| 浦银安盛嘉和稳健一年持有混合(FOF)C | 0.9903 | -0.0472% |
| 浦银安盛双债增强债券A | 1.1863 | -0.0593% |
| 浦银安盛双债增强债券C | 1.1661 | -0.0593% |
| 浦银安盛量化多策略混合A | 1.2341 | -0.0906% |
| 基金名称 | 单位净值 | 日增长率 |
| 工银国家战略股票 | 1.5555 | 0.6769% |
| 招商景气精选股票A | 0.9014 | 0.5160% |
| 招商景气精选股票C | 0.8819 | 0.5160% |
| 能源ETF | 1.5490 | 0.5152% |
| 招商成长 | 3.0536 | 0.4840% |
| 中泰玉衡混合 | 2.2232 | 0.4580% |
| 中泰玉衡价值优选混合C | 2.2080 | 0.4580% |
| 招商科技动力3个月滚动持有股票A | 0.9379 | 0.4508% |
